# BK With VST for Kidney Transplant Patients

> **NCT05042076** · PHASE1 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 3 (actual)

## Conditions studied

- Kidney Transplant Infection
- BK Virus Infection

## Interventions

- **DRUG:** BK-specific T cells from Donor Lymphocytes

## Key facts

- **NCT ID:** NCT05042076
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-16
- **Primary completion:** 2024-05-14
- **Final completion:** 2024-05-14
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2024-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05042076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05042076, "BK With VST for Kidney Transplant Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05042076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*